MDVL Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | 2021 | Ed Kilroy Former Chief Executive Officer | 367,263 | 132,513 | 89,340 | 0 | 497 | 857,476 |
| 2023-05-01 | 2022 | Ed Kilroy Former Chief Executive Officer | 398,797 | 129,220 | 0 | 0 | 2,642 | 530,659 |
| 2023-05-01 | 2022 | Robert McClune | 147,108 | 75,000 | 161,210 | 0 | 159 | 465,728 |
| 2023-05-01 | 2022 | Steven Hess | 277,019 | 0 | 256,760 | 0 | 1,905 | 723,484 |
| 2023-05-01 | 2021 | Ramona Seabaugh Chief Financial Officer, Treasurer and Secretary | 81,250 | 91,797 | 325,000 | 0 | 46 | 823,100 |
| 2023-05-01 | 2022 | Ramona Seabaugh Chief Financial Officer, Treasurer and Secretary | 346,154 | 21,376 | 84,300 | 0 | 414 | 537,218 |
| 2023-05-01 | 2022 | Mark Doerr | 424,038 | 0 | 1,050,001 | 0 | 380 | 2,524,419 |
| 2022-05-02 | 2021 | Ramona Seabaugh | 81,250 | 91,797 | 325,000 | 0 | 46 | 823,100 |
| 2022-05-02 | 2021 | Ed Kilroy Former Chief Executive Officer, President and Director | 367,263 | 132,513 | 89,340 | 0 | 497 | 857,476 |
| 2022-05-02 | 2021 | John Dorsey | 204,981 | 65,178 | 343,132 | 0 | 0 | 1,042,586 |
| 2022-05-02 | 2020 | Ed Kilroy Former Chief Executive Officer, President and Director | 275,764 | 137,275 | 0 | 0 | 0 | 440,771 |
| 2021-04-30 | 2020 | Joseph Mannello Former Chief Executive Officer | 16,970 | 0 | 267,372 | 0 | 11,310 | 295,652 |
| 2021-04-30 | 2020 | Ed Kilroy Chief Executive Officer, President and Director | 275,764 | 137,275 | 0 | 0 | 0 | 440,771 |
| 2021-04-30 | 2019 | Neil Prezioso Chief Pharmacy Officer | 152,354 | 58,333 | 0 | 0 | 0 | 319,618 |
| 2021-04-30 | 2020 | Neil Prezioso Chief Pharmacy Officer | 319,577 | 119,000 | 0 | 0 | 0 | 438,577 |
| 2021-04-30 | 2019 | Ryan Ferguson Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021-04-30 | 2020 | Ryan Ferguson Chief Financial Officer | 249,265 | 140,431 | 0 | 0 | 0 | 552,246 |
| 2021-04-30 | 2019 | Joseph Mannello Former Chief Executive Officer | 23,660 | 0 | 23,663 | 0 | 947 | 48,270 |
| 2021-04-30 | 2019 | Ed Kilroy Chief Executive Officer, President and Director | 320,318 | 0 | 0 | 0 | 0 | 320,318 |
| 2018-11-19 | 2016 | Dr. Robert C. Ashton, Jr. (Former Chief Medical Officer) | 55,687 | 0 | 0 | 0 | 0 | 55,687 |
| 2018-11-19 | 2016 | Joseph Mannello (Chief Executive Officer) | 82,600 | 0 | 12,631 | 0 | 16,081 | 111,312 |
| 2018-11-19 | 2017 | K. Bryce Toussaint (Former Chief Executive Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-11-19 | 2016 | K. Bryce Toussaint (Former Chief Executive Officer) | 173,569 | 0 | 1,755 | 0 | 4,123 | 179,447 |
| 2018-11-19 | 2017 | Joseph C. DosSantos (Former Chief Financial Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-11-19 | 2016 | Joseph C. DosSantos (Former Chief Financial Officer) | 122,437 | 0 | 9,350 | 0 | 37,660 | 169,447 |
| 2018-11-19 | 2017 | Dr. Robert C. Ashton, Jr. (Former Chief Medical Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-11-19 | 2017 | Joseph Mannello (Chief Executive Officer) | 167,400 | 0 | 0 | 0 | 0 | 425,400 |
| 2017-12-11 | 2016 | K. Bryce Toussaint (Former Chief Executive Officer) | 173,569 | 0 | 1,755 | 0 | 4,123 | 179,447 |
| 2017-12-11 | 2016 | Joseph Mannello (Interim Chief Executive Officer) | 82,600 | 0 | 12,631 | 0 | 16,081 | 111,312 |
| 2017-12-11 | 2015 | Joseph Mannello (Interim Chief Executive Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-12-11 | 2015 | Peter Levy (Former President) | 171,475 | 0 | 0 | 0 | 21,165 | 245,340 |
| 2017-12-11 | 2016 | Peter Levy (Former President) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-12-11 | 2015 | Dr. Robert C. Ashton, Jr. (Former Chief Medical Officer) | 237,167 | 50,000 | 0 | 0 | 39,781 | 379,648 |
| 2017-12-11 | 2016 | Dr. Robert C. Ashton, Jr. (Former Chief Medical Officer) | 55,687 | 50,000 | 0 | 0 | 0 | 105,687 |
| 2017-12-11 | 2015 | Joseph C. DosSantos (Former Chief Financial Officer) | 200,000 | 50,000 | 9,350 | 0 | 37,660 | 349,710 |
| 2017-12-11 | 2016 | Joseph C. DosSantos (Former Chief Financial Officer) | 122,437 | 50,000 | 0 | 0 | 0 | 172,437 |
| 2017-12-11 | 2015 | K. Bryce Toussaint (Former Chief Executive Officer) | 9,230 | 0 | 22,700 | 0 | 20,000 | 51,930 |
| 2016-11-22 | 2015 | Carl DeFreitas (Former Chief Financial Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-11-22 | 2015 | K. Bryce Toussaint (Former Chief Executive Officer) | 9,230 | 0 | 22,700 | 0 | 20,000 | 51,930 |
| 2016-11-22 | 2014 | K. Bryce Toussaint (Former Chief Executive Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-11-22 | 2015 | Joseph C. DosSantos (Former Chief Financial Officer) | 200,000 | 50,000 | 9,350 | 0 | 37,660 | 349,710 |
| 2016-11-22 | 2014 | Joseph C. DosSantos (Former Chief Financial Officer) | 130,000 | 15,000 | 0 | 0 | 13,101 | 381,861 |
| 2016-11-22 | 2015 | Dr. Robert C. Ashton, Jr. (Former Chief Medical Officer) | 237,167 | 50,000 | 0 | 0 | 39,781 | 379,648 |
| 2016-11-22 | 2014 | Dr. Robert C. Ashton, Jr. (Former Chief Medical Officer) | 238,257 | 50,000 | 0 | 0 | 29,405 | 454,802 |
| 2016-11-22 | 2015 | Peter Levy (Former President, Chief Operating Officer) | 171,475 | 0 | 0 | 0 | 21,165 | 245,340 |
| 2016-11-22 | 2014 | Peter Levy (Former President, Chief Operating Officer) | 245,833 | 20,000 | 0 | 0 | 21,365 | 321,022 |
| 2016-11-22 | 2014 | Carl DeFreitas (Former Chief Financial Officer) | 70,000 | 0 | 0 | 0 | 122,270 | 256,958 |
| 2016-01-29 | 2014 | Dr. Robert C. Ashton, Jr. (Chief Medical Officer) | 238,257 | 50,000 | 0 | 0 | 29,405 | 454,802 |
| 2016-01-29 | 2015 | K. Bryce Toussaint (Chief Executive Officer) | 9,230 | 0 | 22,700 | 0 | 20,000 | 51,930 |
| 2016-01-29 | 2014 | K. Bryce Toussaint (Chief Executive Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-01-29 | 2015 | Joseph C. DosSantos (Chief Financial Officer) | 200,000 | 50,000 | 9,350 | 0 | 37,660 | 349,710 |
| 2016-01-29 | 2014 | Joseph C. DosSantos (Chief Financial Officer) | 130,000 | 15,000 | 0 | 0 | 13,101 | 381,861 |
| 2016-01-29 | 2015 | Dr. Robert C. Ashton, Jr. (Chief Medical Officer) | 237,167 | 50,000 | 0 | 0 | 39,781 | 379,648 |
| 2016-01-29 | 2015 | Peter Levy (Former President, Chief Operating Officer) | 171,475 | 0 | 0 | 0 | 21,165 | 245,340 |
| 2016-01-29 | 2014 | Peter Levy (Former President, Chief Operating Officer) | 245,833 | 20,000 | 0 | 0 | 21,365 | 321,022 |
| 2016-01-29 | 2015 | Carl DeFreitas (Former Chief Financial Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-01-29 | 2014 | Carl DeFreitas (Former Chief Financial Officer) | 70,000 | 0 | 0 | 0 | 122,270 | 256,958 |
| 2015-11-16 | 2014 | Peter Levy (Former President) | 245,833 | 20,000 | 0 | 0 | 21,365 | 321,022 |
| 2015-11-16 | 2013 | Andrew J. Einhorn (Former Chief Financial Officer) | 18,333 | 0 | 0 | 0 | 17,031 | 35,364 |
| 2015-11-16 | 2014 | Andrew J. Einhorn (Former Chief Financial Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2015-11-16 | 2014 | Glen R. Fleischer (Former Chief Executive Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2015-11-16 | 2013 | Carl DeFreitas (Former Chief Financial Officer) | 0 | 0 | 0 | 0 | 165,000 | 207,800 |
| 2015-11-16 | 2014 | Carl DeFreitas (Former Chief Financial Officer) | 70,000 | 0 | 0 | 0 | 122,270 | 256,958 |
| 2015-11-16 | 2013 | Dr. Robert C. Ashton, Jr. (Chief Medical Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2015-11-16 | 2014 | Dr. Robert C. Ashton, Jr. (Chief Medical Officer) | 238,257 | 50,000 | 0 | 0 | 29,405 | 454,802 |
| 2015-11-16 | 2013 | Glen R. Fleischer (Former Chief Executive Officer) | 105,641 | 0 | 0 | 0 | 0 | 105,641 |
| 2015-11-16 | 2013 | Joseph C. DosSantos (Interim President and Chief Financial Officer) | 0 | 0 | 0 | 0 | 0 | 0 |
| 2015-11-16 | 2014 | Joseph C. DosSantos (Interim President and Chief Financial Officer) | 130,000 | 15,000 | 0 | 0 | 13,101 | 381,861 |
| 2015-11-16 | 2013 | Peter Levy (Former President) | 219,000 | 80,000 | 0 | 0 | 19,913 | 516,913 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
